ResMed
Prix: 194.78Entreprise et modèle économique
ResMed is a healthcare company specializing in cloud-connected devices and software solutions for people with sleep apnea and chronic obstructive pulmonary disease (COPD). Its core products include continuous positive airway pressure (CPAP) devices, masks, and cloud-based software for patient management. The company operates primarily in the sleep and respiratory care segments, with major revenue sources stemming from device sales, software subscriptions, and related accessories.
Profil d’investissement
The investment profile of ResMed is more aligned with balanced investors, given its moderate growth potential and dividend yield. The company offers a steady revenue stream while also providing some income through dividends. However, the elevated risk factors suggest caution for those seeking aggressive growth.
Métriques fondamentales (expérimental)
- BPA (TTM) — bénéfice par action des 12 derniers mois, $
- 10.38 OK
- Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
- 0.6% ≈
- Surprise BPA
- 2.5% conforme
- Volatilité 20 j
- 2.1% stable
- Rendement du dividende
- 1.3% modéré dernière date ex-dividende: 2026-05-14
Suivre dans le portefeuille
Graphique des prix
| Date | Avant | Après | Raison |
|---|---|---|---|
| 2026-06-03 02:51 | Conserver | Vendre | Weak momentum and high risk overshadow potential upside. |
| 2026-05-24 02:49 | Vendre | Conserver | Weak momentum and mixed fundamentals suggest caution. |
| 2026-05-08 15:18 | — | Vendre | Weak momentum and high risk overshadow potential upside. |
| Date | Analyste | Action | Objectif | Prix alors |
|---|---|---|---|---|
| 2026-05-01 12:52 | Robert W. Baird | Objectif abaissé | 254 → 225 | 203.87 |
| 2026-04-27 10:21 | KeyBanc | Objectif abaissé | 302 → 290 | 219.85 |
| 2026-04-13 14:44 | Evercore ISI | Objectif abaissé | 300 → 255 | 228.33 |
Rien pour le moment